Like AltaVoice

closed 1/6/2017 via PR Newswire

InVitae, acquired AltaVoice

synopsis: Invitae Corporation has acquired AltaVoice, a privately owned, patient-centered data company with a global platform for collecting, curating, coordinating, and delivering safeguarded data from patients and clinicians.
buyer: InVitae (NVTA:$389.09)
Invitae, a genetic information company, is aggregating the worlds genetic tests into a single service with better quality, faster turnaround time and lower price than most single-gene tests today. Our mission is to bring genetic information into routine medical practice to improve the quality of hea"
target: AltaVoice
AltaVoice is a patient-centered data company with an innovative story and business model that optimizes the search for better treatments for diseases. They build and host Patient Insights Networks (PINs).
price ($mm)
$5.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/9/2012 via BNC Analysis

TechCapital Group, acquired iHealthEcon

synopsis: TechCapital Group, Life Science Unit has acquired iHealthEcon, a health economics solutions company that helps life sciences organizations plan, develop and advocate health economics to global payers through e-registry-suite.
buyer: TechCapital Group
Established in 1992, TechCapital Group is a private global investment firm that originates, structures and acts as lead equity investor in equity private placements. The R&D management consulting unit provides decision support tools to advanced scientific based engineering groups. "
target: iHealthEcon
iHealthEcon, through e-registry, offers its clients an innovative suite of decision support tools to advance market access by improving the speed and efficiency of collecting health economics and outcomes research registry data in real time to National Health Systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/28/2020 via Company Press Release

JMDC Inc., will acquire MeCompany

synopsis: JMDC Inc., a company that provides medical data statistics, life insurance data statistics, health data platform management, and other services, will be acquiring MeCompany, a database company for medical institutions, dispensing pharmacies, and nursing care establishments using the SCUEL database.
buyer: JMDC Inc. (TSE:4483:$91.75)
JMDC Inc. offers information services. The Company provides medical data statistics, life insurance data statistics, health data platform management, and other services. JMDC provides its services throughout Japan. "
target: MeCompany
Based in Japan, MeCompany is a database company for medical institutions, dispensing pharmacies, and nursing care establishments using the SCUEL database. MeCompany strives to develop a matching service that creates encounters between medical institutions and pharmacies and patients
price ($mm)
$9.76
rev ($mm)
$2
EBITDA ($mm)
EV / rev
4.4x
EV / EBITDA
closed 6/3/2014 via BusinessWire

Fitzroy Health, acquired RJ Health Systems

synopsis: Fitzroy Health, LLC announced the acquisition of RJ Health Systems International, LLC. RJ Health Systems develops products and services that are designed to offer useable knowledge of pharmaceuticals, including cost, billing, management, and utilization review with the goal of promoting the safe and appropriate use of medication.
buyer: Fitzroy Health
Fitzroy Health is an investment and management firm that helps high potential healthcare companies reach scale by investing capital, managing execution, and developing commercialization and expansion strategies. "
target: RJ Health Systems
RJ Health Systems develops products and services that are designed to offer useable knowledge of pharmaceuticals, including cost, billing, management, and utilization review with the goal of promoting the safe and appropriate use of medication.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/23/2013 via BNC Analysis

Optum, acquired Humedica

synopsis: Optum has acquired Humedica. Humedica is the clinical intelligence company that powers health care providers, life sciences and research organizations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.
buyer parent: UnitedHealth Group
buyer: Optum
Optum, through its subsidiaries, provides information and technology-enabled health services. It offers health management solutions that address the physical, mental, and financial needs of individuals and organizations. "
target: Humedica
Humedica is the clinical intelligence company that powers health care providers and life sciences organizations to make better-informed, more confident decisions by transforming unconnected data from multiple sources into real-world insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/29/2014 via BusinessWire

Booz Allen Hamilton Inc., acquired Epidemico

synopsis: Booz Allen Hamilton announced that it has acquired Epidemico, Inc., a move that underscores the firm’s commitment to further develop analytic capabilities areas such as population health. Epidemico is an informatics company providing early insights, continuous monitoring and consumer engagement for varied aspects of population health.
buyer parent: Carlyle Group
buyer: Booz Allen Hamilton Inc. (BAH:$6,366.88)
Booz Allen Hamilton Inc. provides professional services primarily to US government agencies in the defense, security, and civil sectors, as well as to corporations, institutions, and not-for-profit organizations. The company provides a range of services in strategy, operations, and more. "
target: Epidemico
Epidemico is an informatics company established in 2007 that provides early insights, continuous monitoring and consumer engagement for a wide range of population health domains, including disease outbreaks, drug safety, supply chain vulnerabilities and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/7/2013 via Wall Street Journal

Wilmington Group plc, acquired NHiS Ltd

synopsis: Wilmington Group plc, the provider of Information, Compliance, and Education to professional markets announced the acquisition of the entire issued and to be issued share capital of NHiS Limited. NHiS is a leading provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies in the UK.
buyer: Wilmington Group plc (LSE:WIL:$162.62)
Wilmington Group plc is a dynamic and expanding company providing information and training to professional business markets. Their businesses enable professionals and their organizations to perform better by providing quality, relevant and reliable information, education and knowledge. "
target: NHiS Ltd
NHiS is the leading provider of market intelligence and insight to the pharmaceutical sector. NHiS’s products assist organizations in their understanding, engagement and optimization of their markets.
price ($mm)
$8.82
rev ($mm)
$3
EBITDA ($mm)
EV / rev
5.2x
EV / EBITDA
closed 9/13/2011 via PR Newswire

ImpactRx, Inc., acquired TargetRx, Inc.

synopsis: ImpactRx, a Symphony Technology Group company and the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that it has acquired 100% of TargetRx, Inc., a leading provider of insight into the drivers of physician behavior for pharmaceutical companies.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
target: TargetRx, Inc.
TargetRx, Inc. is a leading provider of insight into the drivers of physician behavior for pharmaceutical companies. The company offers a suite of solutions from pipeline to patent expiry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2011 via PR Newswire

Symphony Technology Group, acquired ImpactRx, Inc.

synopsis: ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior, announced that Symphony Technology Group (STG), has acquired a majority ownership interest in the Company. STG is a leading private equity firm with a strategic focus on data, analytics and technology-enabled services companies.
buyer: Symphony Technology Group
Symphony Technology Group (STG) is a strategic private equity firm with the mission of investing in and building great software and services companies. STG also provides transformation expertise to enable its companies to deliver maximum value to its clients. "
target: ImpactRx, Inc.
ImpactRX annually captures three-million treatment decisions, fueling its unique ImpactData™ industry database. ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2007 via BusinessWire

Healthnostics, Inc., acquired MedNets, Inc.

synopsis: Healthnostics, Inc. a medical and biotechnology analytics company, today announced the completion of the MedNets.com acquisition, an Internet portal providing healthcare information resources to consumers and professionals.
buyer: Healthnostics, Inc. (OTCPK:HNSS:$0.20)
Healthnostics, Inc. is a medical and biotechnology analytics company that provides patient clinical monitoring and risk management systems to acute care hospitals, and utilizes its Internet portals to deliver medical and biotechnology resource information. "
target: MedNets, Inc.
MedNets, Inc. offers MedExplore, our medical professional and patient Healthcare Information Directory, through our web site. We have gathered over 20,000 healthcare links in our directory, creating the source to the finest medical information on the Internet.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/26/2007 via PR Newswire

ConnectivHealth, acquired Relegent

synopsis: ConnectivHealth today announced it has acquired Relegent, a Nashville, Tenn.--based provider of health care information to the hospital and education industries. Terms of the deal were not disclosed.
buyer parent: Chrysalis Ventures
buyer: ConnectivHealth
ConnectivHealth is building a network of health care information and new media businesses that enable the delivery, distribution, and organization of important health information for physicians, health care professionals, hospitals, and consumers. "
target: Relegent
Relegent is a leading health care information and marketing firm based in Nashville. Relegent owns and operates HealthTeacher, the leading K-12 online health curriculum. The company also exclusively markets Discovery Hospital content to hospitals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2007 via BusinessWire

MCF Corporation, acquired MedPanel, Inc.

synopsis: MCF Corporation has completed the acquisition of MedPanel, Inc., an online medical market intelligence firm. With the closing of the transaction, MedPanel, Inc. becomes Panel Intelligence, LLC, a wholly owned subsidiary of MCF Corporation.
buyer: MCF Corporation (MEM:$0.00)
MCF Corporation is a financial services holding company that provides investment research, capital markets services, corporate and venture services, investment banking, asset management and wealth management through its operating subsidiaries. "
target: MedPanel, Inc.
MedPanel provides online medical market intelligence to the life sciences industry through custom research and syndicated studies. Research services include study design, recruitment, programming, panel moderation, advanced data analysis and summaries.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/19/2006 via Company Press Release

Reed Elsevier plc, acquired Gold Standard Multimedia

synopsis: Elsevier, a world-leading healthcare and scientific publisher, announced today that it has entered into a definitive agreement to acquire the entire share capital of Gold Standard, Inc., a US-based developer of online clinical drug information products, services and solutions to the healthcare market.
buyer: Reed Elsevier plc (LSE:REL:$9,610.79)
Reed Elsevier is a world leading publisher and information provider. Operating in the scientific, medical, legal, risk and business-to-business sectors, Reed Elsevier provides high value and flexible information solutions to professional end users, with increasing emphasis on internet delivery. "
target: Gold Standard Multimedia
A privately-held company founded in 1993, Tampa, Florida-based Gold Standard Multimedia (GSM) is a leading developer of innovative medical education and drug information software, online services and e-learning solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/20/2005 via BNC Analysis

EBSCO Publishing, Inc., acquired DynaMed, LLC

synopsis: Expanding its presence in the medical arena, EBSCO Publishing (http://www.ebsco.com) announced the acquisition of DynaMed (http://www.dynamicmedical.com), an evidence-based clinical reference tool developed by a physician.
buyer parent: EBSCO Industries, Inc.
buyer: EBSCO Publishing, Inc.
EBSCO Publishing is the world's premier database aggregator, offering a suite of nearly 300 full-text and secondary research databases. EBSCO serves the content needs of all researchers: Academic, Medical, K-12, Public Library, Corporate, Government. "
target: DynaMed, LLC
DynaMed is a point-of-care reference resource designed to provide doctors and medical researchers with the best available evidence to support clinical decision-making.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/17/2013 via PR Web

Healthcare Data Solutions, acquired StratCenter

synopsis: Healthcare Data Solutions, a leading provider of healthcare databases, compliance and business intelligence services, announced the acquisition of StratCenter®, an established leader, delivering the most comprehensive provider facility databases and sales solutions available to the supply chain.
buyer: Healthcare Data Solutions
Healthcare Data Solutions is a leading healthcare information services company focused on building and maintaining the most accurate, compliance-grade data on Physicians, Dentists, Nurse Practitioners and other Healthcare Providers, as well as Pharmacies and Hospitals. "
target: StratCenter
StratCenter was founded in 2002 to provide the healthcare industry with a single point of access to the latest industry news, and to the most comprehensive sets of public and privately-held data on hospitals, IDNs, GPOs, and provider groups.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/14/2018 via PR Newswire

BioInformatics Inc., acquired IMV Ltd.

synopsis: BioInformatics Inc., the leading market research firm supporting the analytical instrumentation and life science industries, and owner of The Science Advisory Board, has acquired IMV Publishing, a recognized leader in market research and online publishing for the medical imaging and clinical diagnostic instruments markets.
buyer: BioInformatics Inc.
BioInformatics Inc. is the leading research and advisory firm serving the life science, diagnostic and analytical instrument industries. Their expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing and validating corporate acquisitions. "
target: IMV Ltd.
IMV Publishing is a recognized leader in market research and online publishing for the medical imaging and clinical diagnostic instruments markets. IMV’s complete line of research reports provides decision makers with site-specific databases and comprehensive market reports.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/4/2010 via Market Wire

TransUnion LLC, acquired MedData

synopsis: TransUnion announced it acquired MedData LLC. The Charlotte-based company provides healthcare insurance information and data solutions for hospitals, physician practices and major healthcare insurance companies. Financial terms of the deal were not disclosed.
buyer: TransUnion LLC (TRU:$2,914.10)
TransUnion is a global leader in credit and information management. The company creates advantages for millions of people around the world by gathering, analyzing and delivering information. For businesses TransUnion delivers comprehensive data and advanced analytics. "
target parent: AGData
target: MedData
MedData is the healthcare division of AGDATA, L.P. MedData was formed to apply and use state-of-the-art database and real-time transaction processing technology for the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/14/2008 via BusinessWire

Health Grades, Inc., acquired Adviware Pty. Ltd.

synopsis: Health Grades, Inc., the leading healthcare ratings company, announces the acquisition of WrongDiagnosis.com, a highly trafficked health information and community Web site. WrongDiagnosis.com was owned by Adviware Pty. Ltd., a privately held company based in Australia.
buyer: Health Grades, Inc. (HGRD:$58.17)
Health Grades, Inc. is the leading healthcare ratings organization, providing ratings and profiles of hospitals, nursing homes and physicians. Millions of patients and many of the nation’s largest employers, health plans and hospitals rely on HealthGrades’ independent ratings and advisory services. "
target: Adviware Pty. Ltd.
Adviware Pty. Ltd owns and operats WrongDiagnosis.com,which includes symptoms, diagnosis and treatment information including a database of statistics and cross-referenced medical information, tools and community forums covering more than 11,000 conditions and treatments.
price ($mm)[EV]
$6.24 [$4.41]
rev ($mm)
$2
EBITDA ($mm)
$1
EV / rev
3.9x
EV / EBITDA
7.2x
closed 4/11/2006 via PR Newswire

Workplace Options, acquired HelpHorizons.com, Inc.

synopsis: Workplace Options, the largest provider of work-life employee benefits in America, today announced the acquisition of HelpHorizons.com, Inc., the country's leading provider of practice management and connectivity solutions for mental health professionals and behavioral health organizations.
buyer: Workplace Options
Workplace Options (WPO) is America's largest provider of work-life services and software that help EAPs and other third-parties run their business more profitably and efficiently. "
target: HelpHorizons.com, Inc.
Dedicated to providing innovative services and information to consumers and mental health professionals. We offer the largest mental health professional referral database online today and technology that supports secure, private e-counseling via e-mail, chat rooms, or videoconferencing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2017 via PR Newswire

InVitae, acquired AltaVoice

synopsis: Invitae Corporation has acquired AltaVoice, a privately owned, patient-centered data company with a global platform for collecting, curating, coordinating, and delivering safeguarded data from patients and clinicians.
buyer: InVitae (NVTA:$389.09)
Invitae, a genetic information company, is aggregating the worlds genetic tests into a single service with better quality, faster turnaround time and lower price than most single-gene tests today. Our mission is to bring genetic information into routine medical practice to improve the quality of hea"
target: AltaVoice
AltaVoice is a patient-centered data company with an innovative story and business model that optimizes the search for better treatments for diseases. They build and host Patient Insights Networks (PINs).
price ($mm)
$5.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/8/2021 via PR Newswire

InVitae, will acquire Ciitizen

synopsis: Invitae will acquire Ciitizen, a patient-centric consumer health tech company. The acquisition will enhance Invitae's platform by providing patients an easy-to-use, centralized hub for their genomic and clinical information, which together comprise a powerful dataset with the potential to drive research and improve healthcare decision making.
buyer: InVitae (NVTA:$389.09)
Invitae Corporation is a leading medical genetics company that brings comprehensive genetic information into mainstream medicine to improve healthcare. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. "
target: Ciitizen
Ciitizen is a leading consumer health technology company whose mission is to help patients get full control of their medical records to access and find better treatment options including participation in research and finding clinical trials.
price ($mm)
$325
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/11/2020 via Company Press Release

InVitae, will acquire YouScript, Inc.

synopsis: Invitae Corportation, a leading medical genetics company, will acquire YouScript, a clinical decision support and analytics platform that enables more proactive medication management. YouScript's Precision Prescribing software helps health care providers to reduce trial-and-error prescribing, reduce expenditures, and improve patient outcomes.
buyer: InVitae (NVTA:$389.09)
Invitae Corporation is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service. "
target: YouScript, Inc.
YouScript a clinical decision support and analytics platform that enables faster, more proactive personalized medication management. YouScript's Precision Prescribing software helps health care providers to reduce trial-and-error prescribing, reduce expenditures, and improve patient outcomes.
price ($mm)
$21
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/11/2020 via PR Newswire

InVitae, acquired Diploid

synopsis: Invitae Corporation, a leading medical genetics company, has acquired Diploid, a privately held Belgian company that developed Moon, artificial intelligence (A.I.) software capable of diagnosing genetic disorders in minutes based on next-generation sequencing data and patient information.
buyer: InVitae (NVTA:$389.09)
Invitae Corporation is a leading medical genetics company that brings comprehensive genetic information into mainstream medicine to improve healthcare. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. "
target: Diploid
Belgium-based Diploid provides clinical labs, hospitals, and nation-wide sequencing programs with the tools to diagnose every rare disease patient. Its Moon platform uses AI software capable of diagnosing genetic disorders in minutes based on next-generation sequencing data and patient information.
price ($mm)
$95
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/20/2019 via Company Press Release

InVitae, will acquire Clear Genetics

synopsis: Invitae Corporation, one of the fastest growing genetic information companies in the U.S., will acquire Clear Genetics, a leading developer of software for providing genetic services at scale whose HIPAA-compliant platform offers an automated and comprehensive solution to deliver genetic services at scale.
buyer: InVitae (NVTA:$389.09)
Invitae is one of the fastest growing genetic information companies in the U.S. Invitae Corporation's mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. "
target: Clear Genetics
Clear Genetics is a Y Combinator company and leader in developing innovative, patient-centric software to thoughtfully integrate genetics into routine patient care. Their HIPAA-compliant platform offers an automated and comprehensive solution to deliver genetic services at scale.
price ($mm)
$50
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/11/2019 via PR Newswire

InVitae, will acquire Jungla Inc.

synopsis: Invitae, a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare, will acquire Jungla, an artificial intelligence driven biotechnology company utilizing computational and cellular modeling to improve clinical genetic tests.
buyer: InVitae (NVTA:$389.09)
Invitae is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare. They aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. "
target: Jungla Inc.
Jungla Inc. is an artificial intelligence driven biotechnology company utilizing computational and cellular modeling to improve clinical genetic tests. Jungla's technologies combine advances in functional genomics, computational biophysics, cellular engineering, and computer science.
price ($mm)
$50
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/12/2017 via PR Newswire

InVitae, acquired CancerGene Connect

synopsis: Invitae Corporation, one of the fastest growing genetic information companies, has acquired Ommdom Inc., which develops healthcare software, including CancerGene Connect, one of the most efficient, end-to-end platforms available for collecting and managing genetic family histories.
buyer: InVitae (NVTA:$389.09)
Invitae is one of the fastest growing genetic information companies in the U.S. Invitae Corporation's mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. "
target: CancerGene Connect
CancerGene Connect is one of the most efficient, end-to-end platforms available for collecting and managing genetic family histories. CancerGene Connect was developed by clinicians for clinicians to streamline the collection, analysis, and management of patient family history information.
price ($mm)
$6.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/6/2017 via PR Newswire

InVitae, acquired AltaVoice

synopsis: Invitae Corporation has acquired AltaVoice, a privately owned, patient-centered data company with a global platform for collecting, curating, coordinating, and delivering safeguarded data from patients and clinicians.
buyer: InVitae (NVTA:$389.09)
Invitae, a genetic information company, is aggregating the worlds genetic tests into a single service with better quality, faster turnaround time and lower price than most single-gene tests today. Our mission is to bring genetic information into routine medical practice to improve the quality of hea"
target: AltaVoice
AltaVoice is a patient-centered data company with an innovative story and business model that optimizes the search for better treatments for diseases. They build and host Patient Insights Networks (PINs).
price ($mm)
$5.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2009 via BusinessWire

Beckman Coulter, Inc., acquired Cogenics

synopsis: Clinical Data, Inc. announced that it has completed the sale of Cogenics, the Company’s genomics services division, to Beckman Coulter, Inc. As previously announced, the sale achieves Clinical Data’s goal to monetize non-core assets and focus resources on advancing its two late-stage targeted therapeutic programs.
buyer: Beckman Coulter, Inc. (BEC:$3,260.60)
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. "
target parent: Clinical Data, Inc.
target: Cogenics
Cogenics’ genomics solutions span current and next generation sequencing, gene expression, clinical and non-clinical genotyping, biomanufacturing support, nucleic acid extraction and biobanking for both research and regulated environments.
price ($mm)
$14
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like AltaVoice


read more

AltaVoice

iHealthEcon

MeCompany

RJ Health Systems

Humedica

Epidemico

NHiS Ltd

TargetRx, Inc.

AlphaImpactRx, Inc

ImpactRx, Inc.

MedNets, Inc.

Relegent

MedPanel, Inc.

Gold Standard Multimedia

DynaMed, LLC

StratCenter

IMV Ltd.

MedData

Adviware Pty. Ltd.

HelpHorizons.com, Inc.

read more

AltaVoice

read more

Ciitizen

YouScript, Inc.

Diploid

Clear Genetics

Jungla Inc.

CancerGene Connect

AltaVoice

read more

Cogenics

Geography
Matching Companies
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,127.03
EBITDA ($mm)
$319.84
EBIT ($mm)
$286.78
Net Income ($mm)
$193.56
Employees
6024
  • drill down
  • watch
Ticker: TSE:4483
 
 
 
 
 
 
 
 
JMDC Inc.
JMDC Inc.
JMDC Inc. offers information services. The Company provides medical data statistics, life insurance data statistics, health data platform management, and other services. JMDC provides its services throughout Japan.
year
2019
rev ($mm)
$91.75
EBITDA ($mm)
EBIT ($mm)
$13.68
Net Income ($mm)
$9.40
Employees
441
  • drill down
  • watch
Ticker: NVTA
 
 
 
 
 
 
 
 
InVitae
Invitae, a genetic information company, is aggregating the worlds genetic tests into a single service with better quality, faster turnaround time and lower price than most single-gene tests today.
year
2021
rev ($mm)
$389.09
EBITDA ($mm)
($510.26)
EBIT ($mm)
($570.07)
Net Income ($mm)
Employees
2600
  • drill down
  • watch
Ticker: BSEM
 
 
 
 
 
 
 
 
BioStem Technologies, Inc.
BioStem Technologies, Inc.
BioStem Technologies, Inc. is engaged in the advancement of regenerative medicine and antiaging strategies throughout the United States, Europe and Mexico. Their goal is to deliver the highest standard wellness and stem cell products that are backed by science.
year
2015
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch